Document:

mess_ex101.htm

EXHIBIT 10.1
 
This loan agreement (the "Agreement") is made by and between messageBgone, Inc., a Nevada corporation (the "Borrower"), and Arraya Wilaiphan (the "Lender"), who make this Agreement on the following terms:
 
The Lender agrees to make loans to the Borrower, from time to time as required, up to the maximum amount of $20,000 in legal US currency.
 
The funds will be lent to the company for no fixed length of time and with no interest, the funds will be paid back when the Company's board of directors decides it is in the company's best interest. 
 
messageBgone, Inc.
 
By: /s/ Arraya Wilaiphan
Name: Arraya Wilaiphan 
Title: Presidentlife-ex101_7.htm

 

Exhibit 10.1

ATYR PHARMA, INC.
SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN

	
1.
	
Purpose

This Senior Executive Cash Incentive Bonus Plan (the “Incentive Plan”) is intended to provide an incentive for superior work and to motivate eligible executives of aTyr Pharma, Inc. (the “Company”) and its subsidiaries toward even higher achievement and business results, to tie their goals and interests to those of the Company and its stockholders and to enable the Company to attract and retain highly qualified executives.  The Incentive Plan is for the benefit of Covered Executives (as defined below).

	
2.
	
Covered Executives

From time to time, the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) may select certain key executives (the “Covered Executives”) to be eligible to receive bonuses hereunder.  Participation in this Plan does not change the “at will” nature of a Covered Executive’s employment with the Company.

	
3.
	
Administration

The Compensation Committee shall have the sole discretion and authority to administer and interpret the Incentive Plan.

	
4.
	
Bonus Determinations

(a)Corporate Performance Goals.  A Covered Executive may receive a bonus payment under the Incentive Plan based upon the attainment of one or more performance objectives that are established by the Compensation Committee and relate to financial and operational metrics with respect to the Company or any of its subsidiaries (the “Corporate Performance Goals”), including the following:  achievement of specified research and development, publication, clinical and/or regulatory milestones, total shareholder return, earnings before interest, taxes, depreciation and amortization, net income (loss) (either before or after interest, taxes, depreciation, stock compensation expense, restructuring charges and/or amortization), changes in the market price of the Company’s common stock, economic value-added, funds from operations or similar measure, sales or revenue, acquisitions or strategic transactions, operating income (loss), cash flow (including, but not limited to, operating cash flow and free cash flow), return on capital, assets, equity, or investment, return on sales, gross or net profit levels, productivity, expense, margins, operating efficiency, customer satisfaction, working capital, earnings (loss) per share of the Company’s common stock, sales or market shares and number of customers, any of which may be (A) measured in absolute terms or compared to any incremental increase, (B) measured in terms of growth, (C) compared to another company or companies or to results of a peer group, (D) measured against the market as a whole and/or as compared to applicable market indices and/or (E) measured on a pre-tax or post-tax basis (if applicable).  Further, any Corporate Performance Goals may be used to measure the performance of the Company as a whole or a business unit or other segment of the Company, or one or more product lines or specific markets.  The Corporate Performance Goals may differ from Covered Executive to Covered Executive. 

 

 

(b)Calculation of Corporate Performance Goals.  At the beginning of each applicable performance period, the Compensation Committee will determine whether any significant element(s) will be included in or excluded from the calculation of any Corporate Performance Goal with respect to any Covered Executive.  In all other respects, Corporate Performance Goals will be calculated in accordance with the Company’s financial statements, generally accepted accounting principles, or under a methodology established by the Compensation Committee at the beginning of the performance period and which is consistently applied with respect to a Corporate Performance Goal in the relevant performance period.   

(c)Target; Minimum; Maximum.  Each Corporate Performance Goal shall have a “target” (100 percent attainment of the Corporate Performance Goal) and may also have a “minimum” hurdle and/or a “maximum” amount. 

(d)Bonus Requirements; Individual Goals.  Except as otherwise set forth in this Section 4(d):  (i) any bonuses paid to Covered Executives under the Incentive Plan shall be based upon objectively determinable bonus formulas that tie such bonuses to one or more performance targets relating to the Corporate Performance Goals, (ii) bonus formulas for Covered Executives shall be adopted in each performance period by the Compensation Committee and communicated to each Covered Executive at the beginning of each performance period and (iii) no bonuses shall be paid to Covered Executives unless and until the Compensation Committee makes a determination with respect to the attainment of the performance targets relating to the Corporate Performance Goals.  Notwithstanding the foregoing, the Compensation Committee may adjust bonuses payable under the Incentive Plan based on achievement of one or more individual performance objectives or pay bonuses (including, without limitation, discretionary bonuses) to Covered Executives under the Incentive Plan based on individual performance goals and/or upon such other terms and conditions as the Compensation Committee may in its discretion determine.

(e)Individual Target Bonuses.  The Compensation Committee shall establish a target bonus opportunity for each Covered Executive for each performance period.  For each Covered Executive, the Compensation Committee shall have the authority to apportion the target award so that a portion of the target award shall be tied to attainment of Corporate Performance Goals and a portion of the target award shall be tied to attainment of individual performance objectives. 

(f)Employment Requirement.  Subject to any additional terms contained in a written agreement between the Covered Executive and the Company, the payment of a bonus to a Covered Executive with respect to a performance period shall be conditioned upon the Covered Executive’s employment by the Company on the bonus payment date.  If a Covered Executive was not employed for an entire performance period, the Compensation Committee may pro rate the bonus based on the number of days employed during such period.

	
5.
	
Timing of Payment

(a)With respect to Corporate Performance Goals established and measured on a basis more frequently than annually (e.g., quarterly or semi-annually), the Corporate Performance Goals will be measured at the end of each performance period after the Company’s financial reports with respect to such period(s) have been published.  If the Corporate Performance Goals and/or individual goals for such period are met, payments will be made as soon as practicable following the end of such period, but not later 74 days after the end of the fiscal year in which such performance period ends.

2

 

 

(b)With respect to Corporate Performance Goals established and measured on an annual or multi-year basis, Corporate Performance Goals will be measured as of the end of each such performance period (e.g., the end of each fiscal year) after the Company’s financial reports with respect to such period(s) have been published.  If the Corporate Performance Goals and/or individual goals for any such period are met, bonus payments will be made as soon as practicable, but not later than 74 days after the end of the relevant fiscal year.   

(c)For the avoidance of doubt, bonuses earned at any time in a fiscal year must be paid no later than 74 days after the last day of such fiscal year.  

	
6.
	
Amendment and Termination

The Company reserves the right to amend or terminate the Incentive Plan at any time in its sole discretion.

	
7.
	
Clawback Policy

Awards under the Incentive Plan shall be subject to the Company’s clawback policy, as in effect from time to time.

3bicx_ex101.htm

EXHIBIT 10.1
  

	 
	1

	

	 

	 
	2

	

	 

	 
	3

	

	 

4DIRECTOR
RESIGNATION AND RELEASE AGREEMENT

 

THIS
DIRECTOR RESIGNATION AND RELEASE AGREEMENT (this “Agreement”) is made and dated as of January 6, 2016 (the
“Effective Date”) by and among Fresh Promise Foods, Inc., a Nevada corporation (“Corporation”) and
Kevin P. Quirk, an individual resident of the State of Georgia (“Quirk”) as follows:

 

RECITALS

 

Quirk
has served as an officer and director of the Corporation since February, 2013 and currently serves as the Corporation’s
chief executive officer and as a member of the board of directors.

 

Quirk
and Corporation have determined that it would be mutually beneficial for Quirk to resign as an officer and as a director of the
corporation.

 

NOW,
THEREFORE, in consideration of their respective rights and obligations, the mutual promises and releases contained herein and
for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereto agree
as follows:

 

AGREEMENT

 

1.Consideration.
In consideration for Quirk’s resignation as chief executive officer of Corporation and as a director of Corporation as provided
in the resignation letter attached hereto as Exhibit A (the “Resignation Letter”), Corporation is entering
into this Agreement. All parties agree that such consideration is just and fair.

 

2.Release
by Corporation and Affiliates. Immediately upon the receipt by Corporation of the Resignation Letter, Corporation, on behalf
of itself and its shareholders, officers, directors, managers, subsidiaries, employees, attorneys, agents, representatives and
affiliates, whether former or current, hereby (a) fully releases, remises, acquits and forever discharges Quirk and each of his
employees, attorneys, agents, representatives, heirs and affiliates, whether former or current, from any and all claims, demands,
actions, causes of action, damages, obligations, liabilities, losses and expenses of whatsoever kind or nature, whether raised
or not, that relate to any actions or omissions (or alleged actions or omissions) of Quirk as a shareholder, employee, officer
and director of Corporation which occurred or existed or may occur or exist at any time before the Effective Date (collectively,
the “Service Activities”), whether or not now known or suspected or claimed, and whether in law, admiralty, arbitration,
administrative, equity or otherwise, and (b) expressly waives any and all claims or rights to assert that any matter, cause, or
thing of any kind or nature whatsoever has been, through oversight or error, either intentionally or unintentionally omitted to
the extent such claims or rights relate to the Service Activities. 

 

3.Release
by Quirk. Effective with the release of the Corporation in Section 2 above, Quirk, on behalf of himself and his employees,
attorneys, agents, representatives, heirs and affiliates, whether former or current, hereby (a) fully releases, remises, acquits
and forever discharges each of Corporation and each of its shareholders, officers, directors, subsidiaries, employees, attorneys,
agents, representatives and affiliates, whether former or current, from any and all claims, demands, actions, causes of action,
damages, obligations, liabilities, losses and expenses of whatsoever kind or nature, whether raised or not, that relate to the
Service Activities which occurred or existed or may occur or exist at any time before the Effective Date, whether or not now known
or suspected or claimed, and whether in law, admiralty, arbitration, administrative, equity or otherwise, and (b) expressly waives
any and all claims or rights to assert that any matter, cause, or thing of any kind or nature whatsoever has been, through oversight
or error, either intentionally or unintentionally omitted to the extent such claims or rights relate to the Service Activities.

 

    	1

    	 

    

 

4.Covenant
Not to Sue. Each of Corporation and Quirk, on behalf of itself and its respective, shareholders, officers, directors, managers,
subsidiaries, employees, attorneys, agents, representatives, heirs and affiliates, whether former or current, hereby covenants
and agrees not to sue (or institute any dispute resolution proceeding against) the other party, or its shareholders, officers,
directors, managers, subsidiaries, employees, attorneys, agents, representatives, heirs and affiliates, whether former or current,
with respect to any issue or matter relating to this Agreement or the Service Activities, which occurred or existed or may occur
or exist at any time before the Effective Date (except a lawsuit to enforce the terms of this Agreement).

 

5.Representations
and Warranties. Each party represents and warrants that it has not heretofore or otherwise transferred to any persons any
claim or potential claim which it may have against the other party, and that it has fully power, right, and authority to execute
this Agreement and to take all steps necessary to implement its terms and conditions. Each party represents and warrants that
no consent of any person or entity not a party to this Agreement is necessary for this Agreement to be fully and completely binding
upon all of the Parties.

 

6.Choice
of Law and Forum. This Agreement is made under and shall be construed and enforced in accordance with the laws of the State
of Georgia without giving effect to its conflicts of law principles that would require or permit a court to consider the laws
of any other state. All matters or disputes relating to the construction and performance of this Agreement shall be litigated
only in the courts of Cobb County, State of Georgia or in the U.S. District Court for the Northern District of Georgia (and no
other).

 

7.Assignment.
No party may assign this Agreement without the prior written consent of all of the other party, such consent not to be unreasonably
delayed, conditioned, or withheld. Any assignments in violation of this provision shall be void.

 

8.Entire
Agreement. This Agreement constitutes and contains the entire agreement and understanding between the parties, and supersedes
and replaces all prior negotiations, representations, or agreements, proposed or otherwise, whether written or oral, concerning
the subject matter hereof. No covenant or condition not expressed in this Agreement shall affect or be effective to interpret,
change, or restrict this Agreement.

 

9.Successors
and Assigns. Every covenant, term, and provision of this Agreement shall be binding upon and inure to the benefit of the parties
hereto and their respective successors, assigns, heirs, legatees, legal representatives, owners, and transferees.

 

    	2

    	 

    

 

10.No
Oral Modification. No change or termination of any provision of this Agreement shall be binding unless in writing signed by
the party against whom enforcement of any waiver, change, modification, or discharge is sought. No representations have been made
to induce any party to enter into this Agreement except for those representations expressly stated herein. No provision of this
Agreement may be waived, except by a writing signed by the party charged with such waiver and such waiver shall be limited to
the terms of such writing. Waiver of any one breach shall not be deemed to be a waiver of any other breach of the same or any
other provision hereof, nor shall any such waiver by any party be deemed to be a continuing waiver. No delay or omission by any
party in exercising any right hereunder, at law or in equity, or otherwise, shall impair any such right, or be construed as a
waiver thereof, or any acquiescence therein, nor shall any single or partial exercise of any right preclude other or further exercise
thereof, or the exercise of any other right.

 

11.Counterparts.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which shall
constitute together but one and the same agreement.

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

	Fresh
    Promise Foods, Inc.	 	 
	 	 	 	 
	By:	/s/
    Scott Martin	 	/s/
    Kevin P. Quirk
	Name:	Scott
    Martin	 	Kevin
    P. Quirk 
	Title:	Director	 	 

 

    	3

    	 

    

 

Exhibit
A

 

Resignation
Letter

 

(see
attached)

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]